The RNA-binding protein LARP1 is a cancer therapeutic target

被引：0
|
作者：
Ghazaly, Essam A. [1 ]
Le Quesne, John [2 ]
Jiang, Dahai [3 ]
Mangala, Selanere L. [3 ]
Chettle, James [4 ]
Rodriguez-Aguayo, Cristian [3 ]
Lopez-Berestein, Gabriel [3 ]
Gnanaranjan, Chathunissa [1 ]
Mura, Manuela [5 ]
Stavraka, Chara [5 ]
Sood, Anil K. [3 ]
Blagden, Sarah P. [4 ]
机构：
[1] Queen Mary Univ London, Barts Canc Inst, London, England
[2] MRC, Toxicol Unit, Leicester, Leics, England
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Oxford, Dept Oncol, Oxford, Oxon, England
[5] Imperial Coll London, Ovarian Canc Act Res Ctr, London, England
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B30
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting the RNA-binding protein LARP1 overcomes therapeutic resistance in ovarian cancer
    Elsayed, Abdelrahman M.
    Amero, Paola
    Bayraktar, Emine
    Sood, Anil K.
    Lopez-Berestein, Gabriel
    Rodriguez-Aguayo, Cristian
    CANCER RESEARCH, 2024, 84 (06)
  • [2] The RNA-binding protein LARP1 is dispensable for pancreatic β-cell function and mass
    Joao Pedro Werneck-de-Castro
    Flavia Leticia Martins Peçanha
    Diego Henrique Silvestre
    Ernesto Bernal-Mizrachi
    Scientific Reports, 11
  • [3] The RNA-binding protein LARP1 is dispensable for pancreatic β-cell function and mass
    Werneck-de-Castro, Joao Pedro
    Pecanha, Flavia Leticia Martins
    Silvestre, Diego Henrique
    Bernal-Mizrachi, Ernesto
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
    Hopkins, Thomas G.
    Mura, Manuela
    Al-Ashtal, Hiba A.
    Lahr, Roni M.
    Abd-Latip, Normala
    Sweeney, Katrina
    Lu, Haonan
    Weir, Justin
    El-Bahrawy, Mona
    Steel, Jennifer H.
    Ghaem-Maghami, Sadaf
    Aboagye, Eric O.
    Berman, Andrea J.
    Blagden, Sarah P.
    NUCLEIC ACIDS RESEARCH, 2016, 44 (03) : 1227 - 1246
  • [5] The mTOR regulated RNA-binding protein LARP1 requires PABPC1 for guided mRNA interaction
    Smith, Ewan M.
    Benbahouche, Nour El Houda
    Morris, Katherine
    Wilczynska, Ania
    Gillen, Sarah
    Schmidt, Tobias
    Meijer, Hedda A.
    Jukes-Jones, Rebekah
    Cain, Kelvin
    Jones, Carolyn
    Stoneley, Mark
    Waldron, Joseph A.
    Bell, Cameron
    Fonseca, Bruno D.
    Blagden, Sarah
    Willis, Anne E.
    Bushell, Martin
    NUCLEIC ACIDS RESEARCH, 2021, 49 (01) : 458 - 478
  • [6] RNA-binding protein 39: a promising therapeutic target for cancer
    Xu, Caipeng
    Chen, Xiaohua
    Zhang, Xuetian
    Zhao, Dapeng
    Dou, Zhihui
    Xie, Xiaodong
    Li, Hongyan
    Yang, Hongying
    Li, Qiang
    Zhang, Hong
    Di, Cuixia
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [7] RNA-binding protein 39: a promising therapeutic target for cancer
    Caipeng Xu
    Xiaohua Chen
    Xuetian Zhang
    Dapeng Zhao
    Zhihui Dou
    Xiaodong Xie
    Hongyan Li
    Hongying Yang
    Qiang Li
    Hong Zhang
    Cuixia Di
    Cell Death Discovery, 7
  • [8] The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration
    Burrows, Carla
    Latip, Normala Abd
    Lam, Sarah-Jane
    Carpenter, Lee
    Sawicka, Kirsty
    Tzolovsky, George
    Gabra, Hani
    Bushell, Martin
    Glover, David M.
    Willis, Anne E.
    Blagden, Sarah P.
    NUCLEIC ACIDS RESEARCH, 2010, 38 (16) : 5542 - 5553
  • [9] Enhanced binding of guanylated poly(A) RNA by the LaM domain of LARP1
    Kozlov, Guennadi
    Jiang, Jianning
    Rutherford, Tyler
    Noronha, Anne M.
    Wilds, Christopher J.
    Gehring, Kalle
    RNA BIOLOGY, 2024, 21 (01) : 7 - 16
  • [10] RNA-Binding Motif Protein 38 as a Potential Biomarker and Therapeutic Target in Cancer
    She, Xiaomin
    Lin, Yan
    Liang, Rong
    Liu, Ziyu
    Gao, Xing
    Ye, Jiazhou
    ONCOTARGETS AND THERAPY, 2020, 13 : 13225 - 13236
12345